Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
59.79
-0.90 (-1.48%)
Apr 29, 2026, 10:17 AM EDT - Market open
Cytokinetics Employees
Cytokinetics had 673 employees as of December 31, 2025. The number of employees increased by 175 or 35.14% compared to the previous year.
Employees
673
Change (1Y)
175
Growth (1Y)
35.14%
Revenue / Employee
$130,816
Profits / Employee
-$1,166,352
Market Cap
7.43B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bio-Techne | 3,100 |
| ImmunityBio | 691 |
| Vaxcyte | 507 |
| Halozyme Therapeutics | 423 |
| Krystal Biotech | 295 |
| Apogee Therapeutics | 261 |
| Kymera Therapeutics | 238 |
| Nuvalent | 228 |
CYTK News
- 1 day ago - Cytokinetics Announces Nine Upcoming Presentations at the European Society of Cardiology Heart Failure 2026 Congress - GlobeNewsWire
- 7 days ago - Cytokinetics to Announce First Quarter Results on May 5, 2026 - GlobeNewsWire
- 8 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - GlobeNewsWire
- 15 days ago - Cytokinetics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 22 days ago - Cytokinetics to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Cytokinetics Announces Four Presentations at the American College of Cardiology Annual Scientific Session & Expo - GlobeNewsWire
- 6 weeks ago - Cytokinetics Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts
- 7 weeks ago - Cytokinetics Transcript: The Citizens Life Sciences Conference 2026 - Transcripts